SAILOR study shows safe, good visual results for ranibizumab in treating neovascular AMD

December 2009
Ocular Surgery News;12/10/2009, Vol. 27 Issue 23, p24
Academic Journal
The article discusses research on the beneficial effect of ranibizumab on visual outcome. It references a study published in 2009 "Ophthalmology." The researchers found that ranibizumab provides safe and well-tolerated results in treating neovascular age-related macular degeneration. The study is called the Safety Assessment of Intravitreous Lucentis for AMD or SAILOR.


Related Articles

  • Where the AMD Clinical Trials Stand. Ciulla, Thomas A.; Regillo, Carl // Review of Ophthalmology; 

    Examines the accuracy of various therapies for age-related macular degeneration (AMD) in Indianapolis, Indiana. Role of nutrition in AMD; Improvement in visual acuity following laser treatment of drusen; Use of photodynamic therapy in activating intravascular dyes for vascular occlusion;...

  • Macular hole surgery now more than 80% successful. Charters, Lynda; Thompson, John T. // Ophthalmology Times; 

    Focuses on macular hole surgery. Vitreoretinal surgical procedures for restoring visual acuity in eyes with macular disease; Cystoid macular edema; Most important prognostic indicator of visual outcome in macular holes.

  • Implantable telescope improves quality of life for patients with advanced AMD. Morgan, Daniel R.; Nale, Patricia; Stiglich, Joan-Marie // Ocular Surgery News;2/25/2014, Vol. 32 Issue 4, p16 

    The article offers information about the Implantable Miniature Telescope from specialty medical device company VisionCare Ophthalmic Technologies.

  • Large-spot-size TTT effective for CNV associated with AMD. Charters, Lynda; Algvere, Peep // Ophthalmology Times;10/15/2003, Vol. 28 Issue 20, p58 

    Evaluates the efficacy of large-spot-size transpupillary thermotherapy (TTT) for the treatment of occult choroidal neovascularization associated with age-related macular degeneration. Description of TTT; Effect of thermal lasers on the neurosensory retina; Means of improving visual acuity.

  • IVAN, CATT meta-analysis increases power of results. Mullin, David W.; Nale, Patricia // Primary Care Optometry News;Jul2012, Vol. 17 Issue 7, p9 

    The article reports on the claim by Doctor Usha Chakravarthy that researchers have proven that there is no difference in the use of bevacizumab or ranibizumab in treating neovascular age-related macular degeneration with regard to visual acuity based on a meta-analysis.

  • Comparative role of intravitreal ranibizumab versus bevacizumab in choroidal neovascular membrane in age-related macular degeneration. Biswas, Partha; Sengupta, Subhrangshu; Choudhary, Ruby; Home, Subhankar; Paul, Ajoy; Sinha, Sourav // Indian Journal of Ophthalmology;May2011, Vol. 59 Issue 3, p191 

    Context: Ranibizumab and bevacizumab are used widely for treating patients with choroidal neovascular membrane (CNVM) secondary to age-related macular degeneration (AMD). Aims: To determine and compare the efficacy and safety of intravitreal ranibizumab and bevacizumab in treatment of CNVM due...

  • A randomised trial of bevacizumab and reduced light dose photodynamic therapy in age-related macular degeneration: the VIA study. Potter, M. J.; Claudio, C. C.; Szabo, S. M. // British Journal of Ophthalmology;Feb2010, Vol. 94 Issue 2, p174 

    Aim To determine if reduced light-dose photodynamic therapy (PDT) combined with bevacizumab will decrease the number of bevacizumab treatments required over 6 months compared with bevacizumab monotherapy in neovascular age-related macular degeneration (AMD). Methods Thirty-six patients with...

  • Low fluence rate photodynamic therapy combined with intravitreal bevacizumab for neovascular age-related macular degeneration. Costagliola, Ciro; Romano, Mario R.; Rinaldi, Michele; dell'Omo, Roberto; Chiosi, Flavia; Menzione, Massimo; Semeraro, Francesco // British Journal of Ophthalmology;Feb2010, Vol. 94 Issue 2, p180 

    Aims To report the efficacy and safety of intravitreal bevacizumab (IVB) alone versus IVB plus low-fluence photodynamic therapy (PDT) in age-related macular degeneration (AMD) patients and to verify the occurrence of a synergistic effect of the combined approach on visual acuity, size and...

  • Retinal vascular changes following intravitreal ranibizumab injections for neovascular AMD over a 1-year period. Wickremasinghe, S S; Xie, J; Guymer, R H; Wong, T Y; Kawasaki, R; Qureshi, S // Eye;Jul2012, Vol. 26 Issue 7, p958 

    PurposeTo assess retinal vascular calibre changes in eyes with neovascular age-related macular degeneration (AMD), treated with intravitreal anti-vascular endothelial growth factor agents, over a 1-year period and compare any such changes to untreated fellow eyes.MethodsTreatment naïve...

  • REAL-WORLD ANTI-VEGF RESULTS. O'Hare, Ryan // Optometry Today;8/8/2015, Vol. 55 Issue 16, p35 

    An abstract of an article regarding a study on the use of ranibizumab drug to treat age-related macular degeneration (AMD) patients with a good initial level visual acuity is presented.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics